Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Youth with Tourette's Disorder
NCT00241176Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in Tourette syndrome (TS) and chronic motor tic disorder, sponsored by NYU Langone Health. Primary endpoint: Yale Global Tic Severity Scale at 8 weeks. Started Sep 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)chronic motor tic disorder
Beyond the preview
Go deeper on NCT00241176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241176.